PTEN and neoplasm: Mice that are heterozygotes for the driver mutation BrafV600E (the most prevalent driver of human melanomas) and deletion of the tumour suppressor PTEN develop sporadic melanomas (Figure 8A) genetically and cytologically comparable to human tumours (Figure 8B).